StockNews.com initiated coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a research report sent to investors on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Performance Shares of NASDAQ VBIV opened at $0.56 on Friday. VBI Vaccines has a 52-week low of $0.45 and […]